The Company uses its know-how in virology to develop and commercialize innovative products that offer cost-effective treatment for a wide range of diseases affecting the population at large. The products under development by AVIR Green Hills Biotechnology are unique therapies against viral infectious diseases and cancer with the aim to significantly improve health and the quality of life of human beings.

AVIR Green Hills Biotechnology´s core competence is its extensive know-how in virology, in particular in the field of interactions between viruses and host cells. This expertise has allowed the Company to establish the product line
“Viral Engineering” which led to the development of two products in late stage of preclinical development and a portfolio of earlier stage programs in the pipeline.